Key facts
- NousQ’s last known valuation is $21.8M (May 2025).
- It has raised $9.6M.
- Notable investors include MedTech Innovator, WEVE Acceleration, National Research Foundation Singapore, Agency for Science, Be Health Ventures — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for NousQ
- ·The full record, as it builds
Funding rounds
No funding rounds for NousQ are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NousQ
Developer of tube insertion surgery technology intended to commercialise medical technology and devices for patients. The company's product offers a novel resolution for glue ears, uniquely programmed by a sensor and an automated algorithm adaptable for different eardrums, enabling clients to reduce cost, surgery risks, and glue ear-related complications.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2021
- Employees
- 11
- Website
- nousq.com/
- Ownership
- Privately Held (backing)
NousQ doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NousQ shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NousQ in its N-PORT filings yet. We sweep new filings monthly.